Line 92: | Line 92: | ||
<div class="row"></div> | <div class="row"></div> | ||
<h1 class="title">Experiments</h1> | <h1 class="title">Experiments</h1> | ||
− | <a href="https://static.igem.org/mediawiki/2018/ | + | <a href="https://static.igem.org/mediawiki/2018/e/e9/T--UST_Beijing--experiment.pdf" class="btn btn-info btn-large btn-rounded">CLICK FOR PDF</a> </div> |
</div> | </div> | ||
</div> | </div> | ||
Line 104: | Line 104: | ||
<div class="row"> | <div class="row"> | ||
<h3><span>Abstract:</span><br></h3> | <h3><span>Abstract:</span><br></h3> | ||
− | <h3>Ginseng products offer unique opportunity to meet the atherosclerosis challenge. | + | <h3>Ginseng products offer unique opportunity to meet the atherosclerosis challenge. Herbs containing ginsenosides include: Ginseng, Western Ginseng, Notoginseng, Jiaogulan etc. Current herb preparation and administration practice results in poor absorption profile limit its efficacy and cost-effectiveness. Since the ginseno-sterols are responsible for their main pharmacological effects, how to achieve effective concentration of sterol in the human body become critical. <br> Our long-term goal is to improve the health-promoting effects of ginsenosides. We believe that sterols (triterpenes)in the ginsenosides are responsible for their main benefits. Therefore in the past projects we engineered synthetic squalene cyclase for in situ production of ginseng-sterols in human cells and produced synthetic β-glucosidase in E.coli for removal of sugar from ginsenosides. In the current strategy, in the wake of “No release” policy of the iGEM community, we are able to by-pass synthetic biology methods to achieve our goal by applying in vitro chemical reactions. </h3> |
− | + | ||
<div class="pad10"></div> | <div class="pad10"></div> | ||
<h3><span>In the past, two approaches have been tried to achieve this: </span></h3> | <h3><span>In the past, two approaches have been tried to achieve this: </span></h3> | ||
Line 115: | Line 114: | ||
<div class="span5"> | <div class="span5"> | ||
<img src="https://static.igem.org/mediawiki/2018/0/05/T--UST_Beijing--ep13.png" alt=""> | <img src="https://static.igem.org/mediawiki/2018/0/05/T--UST_Beijing--ep13.png" alt=""> | ||
− | |||
<div class="span3"></div> | <div class="span3"></div> | ||
<div class="span4" ><img src="https://static.igem.org/mediawiki/2018/3/32/T--UST_Beijing--ep14.png" alt=""></div> | <div class="span4" ><img src="https://static.igem.org/mediawiki/2018/3/32/T--UST_Beijing--ep14.png" alt=""></div> |
Revision as of 00:55, 14 October 2018